ALDEYRA THERAPEUTICS INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by ALDEYRA THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-14PERCEPTIVE ADVISORS LLCAldeyra Therapeutics, Inc.8,593,58614.6%EDGAR
SC 13G2024-02-13VANGUARD GROUP INCAldeyra Therapeutics, Inc.3,927,5976.7%EDGAR
SC 13G2024-01-29BlackRock Inc.Aldeyra Therapeutics, Inc.3,430,7745.8%EDGAR
SC 13G/A2023-10-19PERCEPTIVE ADVISORS LLCAldeyra Therapeutics, Inc.8,593,58614.7%EDGAR
SC 13G2023-10-04Knoll Capital Management, LLCAldeyra Therapeutics, Inc.3,595,9166.1%EDGAR
SC 13G/A2023-02-14PERCEPTIVE ADVISORS LLCAldeyra Therapeutics, Inc.11,350,08519.4%EDGAR
SC 13G/A2023-02-03STATE STREET CORPAldeyra Therapeutics, Inc.-0.3%EDGAR
SC 13G2022-07-08BlackRock Inc.Aldeyra Therapeutics, Inc.974,9471.7%EDGAR
SC 13G/A2022-02-14PERCEPTIVE ADVISORS LLCAldeyra Therapeutics, Inc.9,903,87917.0%EDGAR
SC 13G2022-02-09STATE STREET CORPAldeyra Therapeutics, Inc.-5.3%EDGAR
SC 13G2022-02-04BlackRock Inc.Aldeyra Therapeutics, Inc.3,228,8115.6%EDGAR
SC 13G/A2022-01-04Domain Partners VI, L.P.Aldeyra Therapeutics, Inc.--EDGAR
SC 13G/A2021-02-16683 Capital Management, LLCAldeyra Therapeutics, Inc.216,818-EDGAR
SC 13G/A2021-02-16PERCEPTIVE ADVISORS LLCAldeyra Therapeutics, Inc.8,703,87919.1%EDGAR
SC 13G/A2021-02-12Prosight Management, LPAldeyra Therapeutics, Inc.908,4882.3%EDGAR
SC 13G/A2020-07-13PERCEPTIVE ADVISORS LLCAldeyra Therapeutics, Inc.6,285,45819.1%EDGAR
SC 13G/A2020-07-10BlackRock Inc.Aldeyra Therapeutics, Inc.483,5731.6%EDGAR
SC 13G2020-02-25Prosight Management, LPAldeyra Therapeutics, Inc.1,784,0336.3%EDGAR
SC 13G/A2020-02-14PERCEPTIVE ADVISORS LLCAldeyra Therapeutics, Inc.3,085,45811.0%EDGAR
SC 13G/A2020-02-13683 Capital Management, LLCAldeyra Therapeutics, Inc.1,727,7006.2%EDGAR
External links